-
GlaxoSmithKline's rosiglitazone (Avandia) will receive a black box warning by the FDA because of concerns over heart failure associated with use of the drug.
-
-
-
-
Until recently, available information supported the notion that the transdermal route of administration of estradiol has less hepatic impact than the oral route.
-
Codes and colleagues from France followed a cohort of 251 women with chronic hepatitis C, and report data associating the severity of fibrosis established by liver biopsies with menopause and hormone therapy.
-
-
Aspirin, Higher Doses No More Effective, Risky; Subclinical Hypothyroidism Treatment Benefits; FDA approvals
-
The Million Women Study reported a small increase in the incidence of ovarian cancer and ovarian cancer mortality in current users of postmenopausal hormone therapy.
-
Human Papilloma Virus (HPV) is recognized worldwide as the principal culprit in the development of cervix cancer and its precursor dysplastic lesions. Also increasingly recognized is its role in other anogenital disease such as vulvar, vaginal and perianal warts, dysplasia and cancer.
